How Deviceflow Is Transforming Medical Device Operations With AI-Powered Commercial Infrastructure
From Fragmented Workflows to a Unified Operating System for the $600B Medtech Ecosystem
Oscar Simon Valbuena, Karlens Joas and Ayah Hamdan

Helping Medical Device Teams Move Faster Without Operational Friction
Imagine a surgical team preparing for a procedure. The required instrument tray is not ready. A distributor is texting a field rep, a hospital coordinator is emailing for updates, and operations teams are checking multiple systems to locate inventory. What should be a straightforward workflow turns into a chain of 11 messages across eight people, six different applications, and three days of coordination.
These breakdowns are not rare. They are systemic. Across the medical device industry, critical operational workflows are still managed through fragmented communication channels like email, spreadsheets, and group chats. This lack of visibility creates blind spots that lead to delays and inefficiencies, ultimately impacting patient care. In fact, poor coordination and inventory visibility contribute to a 21% rate of pre-surgery case cancellations, resulting in lost revenue, wasted staff time, and compromised patient experiences.
Deviceflow changes this dynamic. Its platform serves as a commercial operating system for medical device companies, automating the entire order-to-cash lifecycle. From case management and usage capture to purchase order matching, invoicing, inventory tracking, and partner coordination, Deviceflow consolidates previously disconnected workflows into a single intelligent system.
Instead of relying on manual coordination, teams can operate with real-time visibility and automation. The platform is already live, processing more than $1.25 million in transaction volume each month and growing by over 30% month over month.
What once required days of coordination across multiple stakeholders can now happen within a unified system designed for how the industry actually operates.
Why Is This Problem Significant, & How Large Is Its Impact?
Operational inefficiency in the medical device supply chain is not just a workflow issue. It is a structural problem with significant financial and clinical implications.
The impact is substantial:
- The U.S. medical device market exceeds $200 billion, with more than $600 billion globally
- Supply chain inefficiencies account for up to 40% of total product costs
- The industry experiences an obsolescence rate six times higher than other sectors
- Operations teams spend 30% to 50% of their time acting as manual intermediaries between disconnected systems
As infrastructure becomes more complex and data volumes increase, these inefficiencies continue to scale. At the same time, expectations around speed, accuracy, and coordination are rising across healthcare systems.
Deviceflow addresses this by introducing an intelligence layer that transforms unstructured communication into structured, actionable data. By doing so, it enables faster case turnover, improved inventory utilization, and more efficient billing and collections processes.
The company is targeting a $5 billion total addressable market, beginning with a $250 million beachhead in orthopedic customer service and field inventory.
Meet the Team Behind Deviceflow
Deviceflow is led by a founding team with deep experience across healthcare technology, data infrastructure, and enterprise software.
- Anatoly Geyfman (CEO): Anatoly brings over 15 years of experience building companies at the intersection of healthcare and data. He previously founded Carevoyance, a medical device intelligence platform acquired by H1 in 2021, where he later served as VP of Medical Devices. Earlier in his career, he was Chief Architect at Ambra Health, where he built cloud-based medical imaging infrastructure. His experience spans both clinical systems and commercial operations, giving him direct insight into the industry’s operational gaps.
- Daniel Imfeld (CTO): Daniel leads the technical development of Deviceflow’s platform, bringing expertise in building scalable systems and AI-driven infrastructure.
- Jason Katzer (VP of Engineering): Jason oversees engineering execution and platform scalability, ensuring the product can support complex enterprise workflows across the medical device ecosystem.
Together, the team combines deep domain expertise with strong technical execution, positioning them to solve a highly specific and persistent industry problem.


Co-Founder and CEO
“Every device company we talk to has the same problem — talented people spending half their day on work that a system should handle. We didn't set out to build another ERP module. We built a commercial operating system that lets these teams do what they're actually good at — getting life-saving treatments to patients, managing critical relationships, and growing the business. Not reconciling spreadsheets.”
Why We’re Excited to Invest
Deviceflow sits at the intersection of two major trends: the increasing operational complexity of healthcare supply chains and the growing need for AI-native systems that can operate on unstructured data. Unlike traditional ERP systems or lightweight workflow tools, Deviceflow is built as an AI-native platform from the ground up. It captures natural-language communication across emails, texts, and other informal channels, transforming it into structured workflows without requiring users to change their behavior. This is a critical advantage in an industry where adoption friction can prevent even the best tools from scaling.
The platform also benefits from strong network effects. By connecting distributors and manufacturers within a unified system, Deviceflow creates a two-sided network where each interaction improves its underlying models and workflow automation capabilities. Over time, this builds a compounding data moat that is difficult for competitors to replicate. From a go-to-market perspective, Deviceflow is highly aligned with Plug and Play’s health ecosystem. Its focus on distributors and manufacturers aligns closely with our corporate partner base, including Zimmer Biomet and J&J MedTech.
The company has already demonstrated strong early traction, with rapid transaction growth and a capital-efficient model that projects a Customer Acquisition Cost below $1 for every $1 of Annual Recurring Revenue at scale. With $1.5 million raised to date and backing from TeamWorthy Ventures, Founder’s Edge, YZ Ventures, and strategic industry angels, Deviceflow is well-positioned to expand its footprint across the medical device ecosystem. By transforming fragmented communication into a unified operational layer, Deviceflow could become the digital backbone of global medical device operations.
Plug and Play is one of the most active VCs globally. Our goal is to fund the teams building the defensible businesses of the future. Join our ecosystem today.

Discover our global locations
We have a community of experts all over the world. We work as a bridge between Silicon Valley and the rest of the world, making innovation open to anyone, anywhere.





